À retenir
In a meta-analysis of 14 trials with 561 older adults with sarcopenia, resistance training improved handgrip strength (SMD 0.81), knee extension strength (SMD 1.26) and gait speed (SMD 1.28) and reduced body fat mass (SMD -0.53). Muscle mass measures did not clearly change, and heterogeneity was high (I2 up to 89%) for several of the strength and performance outcomes.
Study design
Méta-analyse d’essais
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sarcopenia, the loss of muscle mass and function with age, limits independence, and resistance training is a leading candidate treatment. The authors pooled randomized trials to see how resistance training affects body composition, muscle strength and muscle performance in older people with sarcopenia.
Population et méthode
Systematic review and meta-analysis of randomized controlled trials found in PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure (CNKI) and Wanfang, reviewing data from January 2010 to October 2020. Two researchers independently extracted data and assessed study quality. Pre-post changes were pooled as standardized mean differences (SMD) with 95% confidence intervals. Fourteen studies with 561 healthy older adults aged 65.8 to 82.8 with sarcopenia were included.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Compared with controls, resistance training improved handgrip strength (SMD 0.81, 95% CI 0.35 to 1.27, p = 0.0005, I2 = 81%) and knee extension strength (SMD 1.26, 95% CI 0.72 to 1.80, p < 0.0001, I2 = 67%).
- 2It improved gait speed (SMD 1.28, 95% CI 0.36 to 2.19, p = 0.006, I2 = 89%) and the timed up and go test (SMD -0.93, 95% CI -1.30 to -0.56, p < 0.0001, I2 = 23%), where a negative value means a faster time.
- 3Body fat mass decreased (SMD -0.53, 95% CI -0.81 to -0.25, p = 0.0002, I2 = 0%).
- 4No clear effect was found on appendicular skeletal muscle mass (SMD 0.25, 95% CI -0.27 to 0.78, p = 0.35), skeletal muscle mass (SMD 0.27, 95% CI -0.02 to 0.56, p = 0.07) or leg lean mass (SMD 0.12, 95% CI -0.25 to 0.50, p = 0.52).
- 5Gains in muscle mass, strength and performance differed by age, sex, diagnostic criteria, weight, and by the duration, frequency, mode and intensity of training.
Limites et incertitude
- 1Heterogeneity was high for gait speed (I2 = 89%), handgrip strength (81%) and appendicular muscle mass (68%), so the size of the benefit varied widely between trials.
- 2Only 14 trials and 561 participants were pooled, and the abstract does not report the risk of bias in these trials.
- 3Pre-post changes were pooled, and the abstract does not say what the control groups did.
- 4The abstract does not identify which training programs worked best, and the authors call the participants healthy despite having sarcopenia. This reading is based on the abstract only.
Mise en perspective
These results support supervised resistance training as a way to improve strength and walking performance in older adults with sarcopenia, even though measured muscle mass did not clearly change. They do not tell you the best program or how long to train. Anyone with sarcopenia or frailty should plan exercise with their clinician or a qualified trainer.
Vos données
Grip strength, chair-stand or walking speed tests, and a log of weekly resistance sessions are practical ways to follow progress. Wearables can show gait speed trends or step counts, but compare under the same conditions, and expect strength to change before muscle mass on a scale or body composition reading.
Comprendre ce type de preuve
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Objective
We conducted a meta-analysis to analyze the effects of resistance training on measures of body composition, muscle strength, and muscle performance in older people with sarcopenia.
Methods
All randomized controlled trials on the effects of resistance training on outcome variables in older people with sarcopenia were searched on Pubmed, Embase, Cochrane Library, the China National Knowledge Infrastructure (CNKI), and Wanfang. Data from January 2010 to October 2020 were reviewed. Two researchers extracted data and evaluated the quality of the studies that met the inclusion criteria independently. Meta-analysis for pre-post changes were calculated as standardized mean difference (SMD) with 95% confidence intervals (CI).
Results
Fourteen studies meeting inclusion criteria included 561 healthy older adults (age 65.8 to 82.8) with sarcopenia. Compared with the control group, resistance training had positive effects on body fat mass (SMD = -0.53, 95% CI - 0.81 to - 0.25, p = 0.0002, I^(2) = 0%), handgrip strength (SMD = 0.81, 95%CI 0.35 to 1.27, p = 0.0005, I^(2) = 81%), knee extension strength (SMD = 1.26, 95% CI 0.72 to 1.80, p < 0.0001, I^(2) = 67%), gait speed (SMD = 1.28, 95%CI 0.36 to 2.19, p = 0.006, I^(2) = 89%), and the timed up and go test (SMD = -0.93, 95% CI - 1.30 to - 0.56, p < 0.0001, I^(2) = 23%). Resistance training had no effects on appendicular skeletal muscle mass (SMD = 0.25, 95% CI - 0.27 to 0.78, p = 0.35, I^(2) = 68%), skeletal muscle mass (SMD = 0.27, 95% CI - 0.02 to 0.56, p = 0.07, I^(2) = 0%) and leg lean mass (SMD = 0.12, 95% CI - 0.25 to 0.50, p = 0.52, I^(2) = 0%). Old people with sarcopenia of different ages, genders or diagnostic criteria and weights have different gains in muscle mass, handgrip strength, knee extension strength and muscle performance after different intervention duration, frequencies, mode and intensity resistance training.
Conclusion
Resistance training is an effective treatment to improve body fat mass, muscle strength, and muscle performance in healthy older people with sarcopenia.
Sources et attribution
Effects of resistance training in healthy older people with sarcopenia: a systematic review and meta-analysis of randomized controlled trials.
Chen N, He X, Feng Y, Ainsworth BE, Liu Y.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2021-11-11
DOI: 10.1186/s11556-021-00277-7 ↗PubMed · 34763651 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

